CJC-1295 DAC Dosing Protocol: 5 mg Vial — Multi-Week Supply Guide

CJC-1295 DAC Dosing Protocol: 5 mg Vial — Multi-Week Supply Guide

Quickstart highlights

CJC-1295 DAC with the Drug Affinity Complex maleimide modification produces serum half-life of 6–8 days via albumin binding, enabling once-weekly GHRH stimulation.

  • Concentration: 2 mg/mL (5 mg vial + 2.5 mL bacteriostatic water).
  • At 2 mg/mL: 1 mg = 50 units, 2 mg = 100 units once weekly.
  • One 5 mg vial covers 5 injections at 1 mg/week or 2.5 injections at 2 mg/week.
  • CJC-1295 DAC half-life: 6–8 days — once-weekly dosing is sufficient for therapeutic GH elevation.
  • Refrigerate; use within 28 days.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-4100050Once weekly1 mg — 50 units; 5 mg vial provides 5 weekly doses
5-122000100Once weekly2 mg — 100 units; 5 mg vial provides 2.5 weekly doses at this level

Your free CJC-1295 DAC tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Add your listing Already have one? Sign in

Reconstitution steps

  1. Draw 2.5 mL bacteriostatic water; inject slowly down the vial wall.
  2. Swirl gently until lyophilized powder dissolves; do not shake.
  3. Final concentration: 2 mg/mL. Label with date; refrigerate at 2–8 °C. Use within 28 days.
  4. Note: at 2 mg weekly dosing, one 5 mg vial provides 2 full injections plus one 1 mg partial — plan accordingly.

Supplies needed

8-week plan

  • 2 vials
  • 8 syringes
  • 5 mL bac water
  • 8 alcohol swabs

12-week plan

  • 3 vials
  • 12 syringes
  • 8 mL bac water
  • 12 alcohol swabs
Need clinics? See vetted providers →
Advertisement

Protocol overview & cycle notes

Provide a multi-week CJC-1295 DAC supply from the efficient 5 mg vial for patients established on once-weekly 1–2 mg dosing protocols, minimizing reconstitution frequency.

Cycle length: 12 weeks on.

Off-cycle: 4–6 weeks off; measure IGF-1 before resuming.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted at 2 mg/mL: refrigerate 2–8 °C; use within 28 days. At 1 mg weekly: one 5 mg vial covers 5 weekly injections. At 2 mg weekly: covers 2.5 weekly injections (less than 3 weeks).

Injection & tracking tips

  • CJC-1295 DAC's once-weekly dosing allows injection on any convenient day; maintain consistent weekly interval (±24 hours).
  • Combine with a daily GHRP (ipamorelin 200 µg at bedtime) for maximum GH axis activation while maintaining the convenient weekly DAC schedule.
  • The 5 mg vial is most efficient for 1 mg weekly dosing — provides 5 weeks from a single reconstitution.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Measure IGF-1 at baseline, 4 weeks, and 8 weeks.
  • Track fasting glucose monthly — sustained GH elevation from DAC formulation may impair insulin sensitivity over time.
  • Monitor for carpal tunnel symptoms (wrist tingling) — a common early indicator of supraphysiological GH levels.
Log your cycle in the calculator →

How this works & references

CJC-1295 DAC with the Drug Affinity Complex maleimide modification produces serum half-life of 6–8 days via albumin binding, enabling once-weekly GHRH stimulation. The 5 mg vial at 2 mg/mL provides 5 weekly 1 mg doses or 2.5 weekly 2 mg doses from a single reconstitution event, improving sterility management over smaller vials.

Frequently asked questions

Is 2 mg weekly the correct dose for most patients?
2 mg weekly is the most commonly used CJC-1295 DAC dose in compounding protocols. The Teichman trial used weight-based dosing (30–60 µg/kg); for a 70 kg adult, that ranges from 2.1–4.2 mg weekly. Most protocols cap at 2 mg to balance efficacy with manageable IGF-1 elevation.
Can I use the 5 mg vial for twice-weekly dosing?
At 2 mg 2x weekly (4 mg/week total), one 5 mg vial provides slightly more than one week's supply. At this frequency and dose, 5 mg vials require weekly reconstitution — the 10 mg vial would be more practical for twice-weekly protocols.
How does IGF-1 track week-by-week with CJC-1295 DAC?
IGF-1 rises progressively: +20–30% above baseline after the first injection, +35–60% by week 4, plateauing at +50–80% above baseline by 8–12 weeks with continued once-weekly dosing.
What happens to GH secretion during the off-cycle?
After stopping CJC-1295 DAC, IGF-1 declines to near-baseline within 2–4 weeks as the albumin-bound peptide clears. Endogenous GH secretion returns to pre-treatment patterns. No rebound suppression occurs, unlike exogenous HGH withdrawal.
Do I need to keep the 5 mg vial cold immediately after reconstitution?
Yes — refrigerate immediately after reconstitution (2–8 °C). Do not leave at room temperature for more than 2 hours. CJC-1295 DAC degrades faster in solution than lyophilized; proper cold storage is critical for maintaining potency over the 28-day window.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.